PACT Pharma logo

PACT Pharma Funding & Investors

Hayward, CA

PACT Pharma, Inc. operates as a biotechnology company. The Company develops personalized adoptive cell therapies designed for the eradication of solid tumors. PACT Pharma focuses on re-programming immune system to target and to eradicate the cancer. PACT Pharma serves customers in the State of California.

pactpharma.com

Total Amount Raised: $200,000,000

PACT Pharma Funding Rounds

  • Series C

    $75,000,000

    Series C Investors

    Vida Ventures
    Pontifax
    Wu Capital
    Foresite Capital
    Zhejiang Canaan Technology
    Taiho Ventures
    GV
    Droia Ventures
    Casdin Capital
    AbbVie Biotech Ventures
    Invus Opportunities
  • Series B

    $95,000,000

    Series B Investors

    GV
    Canaan Partners
    Invus
    Casdin Capital
    UpHonest Capital
    Wei Guo
  • Series A

    $30,000,000

    Series A Investors

    GV
Funding info provided by Diffbot.